External Validation of Adjuvant! Online Breast Cancer Prognosis Tool. Prioritising Recommendations for Improvement | PLOS ONE
![Development and pilot of an online, personalized risk assessment tool for a breast cancer precision medicine trial | npj Breast Cancer Development and pilot of an online, personalized risk assessment tool for a breast cancer precision medicine trial | npj Breast Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41523-021-00288-8/MediaObjects/41523_2021_288_Fig1_HTML.png)
Development and pilot of an online, personalized risk assessment tool for a breast cancer precision medicine trial | npj Breast Cancer
![Redefining breast cancer subtypes to guide treatment prioritization and maximize response: Predictive biomarkers across 10 cancer therapies - ScienceDirect Redefining breast cancer subtypes to guide treatment prioritization and maximize response: Predictive biomarkers across 10 cancer therapies - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1535610822002161-fx1.jpg)
Redefining breast cancer subtypes to guide treatment prioritization and maximize response: Predictive biomarkers across 10 cancer therapies - ScienceDirect
![The incidence of discordant clinical and genomic risk in patients with invasive lobular or ductal carcinoma of the breast: a National Cancer Database Study | npj Breast Cancer The incidence of discordant clinical and genomic risk in patients with invasive lobular or ductal carcinoma of the breast: a National Cancer Database Study | npj Breast Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41523-021-00366-x/MediaObjects/41523_2021_366_Fig1_HTML.png)
The incidence of discordant clinical and genomic risk in patients with invasive lobular or ductal carcinoma of the breast: a National Cancer Database Study | npj Breast Cancer
![Biomarkers for Adjuvant Endocrine and Chemotherapy in Early-Stage Breast Cancer: ASCO Guideline Update | Journal of Clinical Oncology Biomarkers for Adjuvant Endocrine and Chemotherapy in Early-Stage Breast Cancer: ASCO Guideline Update | Journal of Clinical Oncology](https://ascopubs.org/na101/home/literatum/publisher/asco/journals/content/jco/2022/jco.2022.40.issue-16/jco.22.00069/20230316/images/abs-fig.jpg)
Biomarkers for Adjuvant Endocrine and Chemotherapy in Early-Stage Breast Cancer: ASCO Guideline Update | Journal of Clinical Oncology
![Validity of Adjuvant! Online program in older patients with breast cancer: a population-based study - The Lancet Oncology Validity of Adjuvant! Online program in older patients with breast cancer: a population-based study - The Lancet Oncology](https://www.thelancet.com/cms/attachment/d9703228-fc3a-4361-8574-cece79e56c05/gr1.jpg)
Validity of Adjuvant! Online program in older patients with breast cancer: a population-based study - The Lancet Oncology
![Prediction models in cancer care - Vickers - 2011 - CA: A Cancer Journal for Clinicians - Wiley Online Library Prediction models in cancer care - Vickers - 2011 - CA: A Cancer Journal for Clinicians - Wiley Online Library](https://acsjournals.onlinelibrary.wiley.com/cms/asset/57900c48-ea3e-4a94-83a6-3ca44db35abd/mfig005.jpg)
Prediction models in cancer care - Vickers - 2011 - CA: A Cancer Journal for Clinicians - Wiley Online Library
![Magee Equations™ and response to neoadjuvant chemotherapy in ER+/HER2-negative breast cancer: a multi-institutional study - Modern Pathology Magee Equations™ and response to neoadjuvant chemotherapy in ER+/HER2-negative breast cancer: a multi-institutional study - Modern Pathology](https://mp.uscap.org/cms/asset/9ae860b0-dcac-4b6d-9b51-565655ad9366/gr1.jpg)
Magee Equations™ and response to neoadjuvant chemotherapy in ER+/HER2-negative breast cancer: a multi-institutional study - Modern Pathology
![JPM | Free Full-Text | Clinical Utility of Gene Expression Profiling Data for Clinical Decision-Making Regarding Adjuvant Therapy in Early Stage, Node-Negative Breast Cancer: A Case Report JPM | Free Full-Text | Clinical Utility of Gene Expression Profiling Data for Clinical Decision-Making Regarding Adjuvant Therapy in Early Stage, Node-Negative Breast Cancer: A Case Report](https://www.mdpi.com/jpm/jpm-02-00071/article_deploy/html/images/jpm-02-00071-g001.png)
JPM | Free Full-Text | Clinical Utility of Gene Expression Profiling Data for Clinical Decision-Making Regarding Adjuvant Therapy in Early Stage, Node-Negative Breast Cancer: A Case Report
![Randomized Trial of Standard Adjuvant Chemotherapy Regimens Versus Capecitabine in Older Women With Early Breast Cancer: 10-Year Update of the CALGB 49907 Trial | Journal of Clinical Oncology Randomized Trial of Standard Adjuvant Chemotherapy Regimens Versus Capecitabine in Older Women With Early Breast Cancer: 10-Year Update of the CALGB 49907 Trial | Journal of Clinical Oncology](https://ascopubs.org/na101/home/literatum/publisher/asco/journals/content/jco/2019/jco.2019.37.issue-26/jco.19.00647/20190827/images/large/jco.19.00647ta1.jpeg)
Randomized Trial of Standard Adjuvant Chemotherapy Regimens Versus Capecitabine in Older Women With Early Breast Cancer: 10-Year Update of the CALGB 49907 Trial | Journal of Clinical Oncology
External Validation of Adjuvant! Online Breast Cancer Prognosis Tool. Prioritising Recommendations for Improvement | PLOS ONE
![Cancers | Free Full-Text | A Comparison between the Online Prognostic Tool PREDICT and myBeST for Women with Breast Cancer in Malaysia Cancers | Free Full-Text | A Comparison between the Online Prognostic Tool PREDICT and myBeST for Women with Breast Cancer in Malaysia](https://www.mdpi.com/cancers/cancers-15-02064/article_deploy/html/images/cancers-15-02064-g001.png)
Cancers | Free Full-Text | A Comparison between the Online Prognostic Tool PREDICT and myBeST for Women with Breast Cancer in Malaysia
![A common language in neoadjuvant breast cancer clinical trials: proposals for standard definitions and endpoints - The Lancet Oncology A common language in neoadjuvant breast cancer clinical trials: proposals for standard definitions and endpoints - The Lancet Oncology](https://www.thelancet.com/cms/attachment/fe468876-c413-4818-b918-0f871d688eda/gr1_lrg.jpg)
A common language in neoadjuvant breast cancer clinical trials: proposals for standard definitions and endpoints - The Lancet Oncology
![Adjuvant Treatment for Older Women with Invasive Breast Cancer - Trevor A Jolly, Grant R Williams, Sita Bushan, Mackenzi Pergolotti, Kirsten A Nyrop, Ellen L Jones, Hyman B Muss, 2016 Adjuvant Treatment for Older Women with Invasive Breast Cancer - Trevor A Jolly, Grant R Williams, Sita Bushan, Mackenzi Pergolotti, Kirsten A Nyrop, Ellen L Jones, Hyman B Muss, 2016](https://journals.sagepub.com/cms/10.2217/whe.15.92/asset/images/large/10.2217_whe.15.92-fig2.jpeg)
Adjuvant Treatment for Older Women with Invasive Breast Cancer - Trevor A Jolly, Grant R Williams, Sita Bushan, Mackenzi Pergolotti, Kirsten A Nyrop, Ellen L Jones, Hyman B Muss, 2016
![It's not time to abandon routine screening mammography in average-risk women in their 40s | MDedge ObGyn It's not time to abandon routine screening mammography in average-risk women in their 40s | MDedge ObGyn](https://cdn.mdedge.com/files/s3fs-public/obgm03210-pearlman_web_t1.jpg)